Department of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing, China.
Oral Dis. 2020 Jul;26(5):983-997. doi: 10.1111/odi.13317. Epub 2020 Apr 13.
To analyze the heterogeneity of fibroblasts isolated from the fibrous capsules of radicular cysts and explore the effects of fibroblast subsets on bone destruction.
Radicular cysts were divided into groups according to varying perilesional sclerosis identified by radiograph. Colony-forming units (CFUs) were isolated from the fibrous capsules of cysts, by which Trap + MNCs were induced, and the expression of osteoclastogenesis-related genes was compared among groups by real-time PCR. The variances in gene profiles of CFUs were identified by principal component analysis, and then, CFUs were divided into subsets using cluster analysis. The induction of Trap + MNCs and related gene expression was compared among subsets, and osteoclastogenic induction was blocked by IST-9 or bevacizumab. The fibroblast subsets in cysts were investigated by retrospective immunostaining with IST-9, VEGF-A, and CD34. A fibroblast subset that underwent gene editing by CRISPR/Cas was injected into the site of bone defects in animal models, and the in vivo effects on osteoclastogenesis were investigated.
The fibroblast CFUs isolated from radicular cysts with perilesional unsclerotized cysts induced more Trap + MNCs than those with perilesional sclerotic cysts (p < .05). Most fibroblast CFUs from unsclerotized cysts belonged to Cluster 2, which induced more Trap + MNCs (p < .05) and highly expressed genes facilitating osteoclastogenesis; these results were different from those of Cluster 1 (p < .05), in which most CFUs were isolated from perilesional sclerotic cysts or controls (p < .05). The high expression of EDA + FN and VEGF-A was investigated in both the fibroblasts of Cluster 2 and the fibrous capsules of unsclerotized cysts (p < .05), and the number of Trap + MNCs induced by Cluster 2 was decreased by treatment with IST-9 and bevacizumab (p < .05). Consistently, EDA exon exclusion significantly decreased the osteoclastogenic induction of fibroblasts from Cluster 2 in vivo (p < .05).
The fibrous capsules of radicular cysts contain heterogeneous fibroblasts that can form subsets exhibiting different effects on osteoclastogenesis. The subset, which depending on the autocrine effects of EDA + FN on VEGF-A, mainly contributes to the osteoclastogenesis and bone destruction of radicular cysts. The regulation of the proportion of subsets is a possible strategy for artificially interfering with osteoclastogenesis.
分析从根囊肿纤维囊分离的成纤维细胞的异质性,并探讨成纤维细胞亚群对骨破坏的影响。
根据影像学显示的病变周围硬化情况,将根囊肿分为不同组。通过集落形成单位(CFU)从囊肿的纤维囊中分离,诱导 Trap+MNCs,并通过实时 PCR 比较各组之间与破骨细胞形成相关的基因表达。通过主成分分析鉴定 CFU 的基因谱差异,然后通过聚类分析将 CFU 分为亚群。比较亚群之间 Trap+MNCs 的诱导和相关基因表达,并使用 IST-9 或 bevacizumab 阻断破骨细胞诱导。通过 IST-9、VEGF-A 和 CD34 进行回顾性免疫染色研究囊肿中的成纤维细胞亚群。通过 CRISPR/Cas 对成纤维细胞亚群进行基因编辑,并将其注射到动物模型的骨缺损部位,研究体内对破骨细胞形成的影响。
从病变周围未硬化囊肿中分离的根囊肿成纤维细胞 CFU 比病变周围硬化囊肿中的 CFU 诱导更多的 Trap+MNCs(p<0.05)。大多数来自未硬化囊肿的成纤维细胞 CFU 属于 Cluster 2,它诱导更多的 Trap+MNCs(p<0.05)并高度表达促进破骨细胞形成的基因;这些结果与 Cluster 1 不同(p<0.05),其中大多数 CFU 是从病变周围硬化囊肿或对照中分离出来的(p<0.05)。Cluster 2 的成纤维细胞和未硬化囊肿的纤维囊中均高表达 EDA+FN 和 VEGF-A(p<0.05),用 IST-9 和 bevacizumab 处理后,Cluster 2 诱导的 Trap+MNCs 数量减少(p<0.05)。同样,EDA 外显子排除显著降低了体内 Cluster 2 成纤维细胞的破骨细胞诱导作用(p<0.05)。
根囊肿的纤维囊中含有异质性成纤维细胞,可形成不同程度影响破骨细胞形成的亚群。该亚群主要依赖于 EDA+FN 对 VEGF-A 的自分泌作用,主要促进根囊肿的破骨细胞形成和骨破坏。调节亚群的比例可能是人为干预破骨细胞形成的一种策略。